Wave of AI and data science tools set to transform clinical trials
Wave of AI and data science tools set to transform clinical trials
Publish Date: 2026-04-30 09:28:00
Source Domain: www.clinicaltrialsarena.com
Biomed Israel will take place from 12-14 May 2026. Credit: Biomed Israel 2025
The clinical trial sector is experiencing a rapid influx of artificial intelligence (AI) and data science tools, as companies seek to improve efficiency and reduce high failure rates in drug development.
At Biomed Israel, taking place from 12-14 May, Ittai Harel, managing partner at Pitango Venture Capital, will lead a session on “Reinventing clinical trials: new models, technologies, and companies”.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Find out more
The discussion will focus on how advances in clinical trial design and execution, including digital platforms, decentralised trials, adaptive methodologies, and data-driven patient recruitment, are beginning to challenge established approaches to clinical development.
Ittai Harel, managing partner at Pitango Venture Capital
Dikla Shpangental, senior vice president and general manager for Switzerland, Israel, and South Asia at IQVIA, will deliver the keynote presentation, alongside presentations from companies including PhaseV, ImmunAI, QuantHealth, NucleAI, Leal Health and Yonalink/Veeva.
This interview has been edited for length and clarity.
Abigail Beaney (AB): What are some of the main innovations you are seeing in the clinical trial space?
Ittai Harel (IH): Over the years in pharma, some areas have seen a lot of change, and others have…
